Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Gonzalez-Angulo

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
The Oncologist|December 8, 2011
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancerJing Li, Ana M Gonzalez-Angulo, Pamela K Allen, et al.
Molecular Cancer Therapeutics|December 7, 2018
Cooperative Effect of Oncogenic <i>MET</i> and <i>PIK3CA</i> in an HGF-Dominant Environment in Breast CancerShuying Liu, Shunqiang Li, Bailiang Wang, et al.
Springerplus|October 25, 2013
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinomaSavitri Krishnamurthy, Wendy Woodward, Wei Yang, et al.
Annals of Surgical Oncology|May 6, 2010
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapyRanjna Sharma, Isabelle Bedrosian, Anthony Lucci, et al.
Cancer Immunology Research|April 26, 2014
PD-L1 expression in triple-negative breast cancerElizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancerRoman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerAna M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patientsCarmen P Escalante, Christina Meyers, James M Reuben, et al.
Annals of Surgery|January 7, 2011
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planningMin Yi, Thomas A Buchholz, Funda Meric-Bernstam, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
The Oncologist|December 8, 2011
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancerJing Li, Ana M Gonzalez-Angulo, Pamela K Allen, et al.
Molecular Cancer Therapeutics|December 7, 2018
Cooperative Effect of Oncogenic <i>MET</i> and <i>PIK3CA</i> in an HGF-Dominant Environment in Breast CancerShuying Liu, Shunqiang Li, Bailiang Wang, et al.
Springerplus|October 25, 2013
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinomaSavitri Krishnamurthy, Wendy Woodward, Wei Yang, et al.
Annals of Surgical Oncology|May 6, 2010
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapyRanjna Sharma, Isabelle Bedrosian, Anthony Lucci, et al.
Cancer Immunology Research|April 26, 2014
PD-L1 expression in triple-negative breast cancerElizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancerRoman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerAna M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patientsCarmen P Escalante, Christina Meyers, James M Reuben, et al.
Annals of Surgery|January 7, 2011
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planningMin Yi, Thomas A Buchholz, Funda Meric-Bernstam, et al.
Pageof 15